0.0465
-0.00125 (-2.62%)
-0.00125 (-2.62%)
Upgrade to Real-Time
Market Closed
Low
0.0441
High
0.0924
Best deals to access real time data! |
|
Small Cap Basic
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Elite Pharmaceuticals Inc (QB) | ELTP | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.00125 | -2.62% | 0.0465 | 16:30:47 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.048 | 0.0465 | 0.05 | 0.0465 | 0.04775 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.0441 | 0.05 | 0.0058 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 33 | 373,387 | $ 0.048551 | $ 18,128 | - | 0.0441 - 0.0924 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:50:59 | 4,507 | $ 0.0465 | USD |
Period:
Draw Mode:
Elite Pharmaceuticals Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 47.02M | 1.01B | 793.80M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 12.25k | $ - | - | - | - |
Elite Pharmaceuticals (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ELTP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0441 | 0.05 | 0.0441 | 0.0475207 | 440,293 | 0.0024 | 5.44% |
| 1 Month | 0.051 | 0.05325 | 0.0441 | 0.0495815 | 918,949 | -0.0045 | -8.82% |
| 3 Months | 0.05415 | 0.0628 | 0.0441 | 0.0536526 | 912,121 | -0.00765 | -14.13% |
| 6 Months | 0.058 | 0.0924 | 0.0441 | 0.0606623 | 1,152,267 | -0.0115 | -19.83% |
| 1 Year | 0.063 | 0.0924 | 0.0441 | 0.0605495 | 1,081,161 | -0.0165 | -26.19% |
| 3 Years | 0.11 | 0.141 | 0.0333 | 0.0752781 | 878,935 | -0.0635 | -57.73% |
| 5 Years | 0.19025 | 0.2495 | 0.0333 | 0.1022483 | 918,463 | -0.14375 | -75.56% |
Elite Pharmaceuticals (QB) Description
| Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, TAGI Pharma, and Glenmark Pharmaceuticals, Inc. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. |
